Abstract:Radiotherapy is one of the most common cancer treatment approaches. Yet its therapeutic outcome has been significantly restricted by tumor hypoxia. Despite glucose oxidase (GOx) coupled with catalase (CAT) or CAT‐like nanoenzymes can be used for tumor oxygenation for synergistic cancer starving‐like/radiation therapies, direct intratumoral injection is restricted to solid tumors with known and accessible sites. Systemic delivery of GOx and CAT/CAT‐like nanoenzymes cascade with tumor‐targeting nanomaterials has the potential to enhance tumor oxygenation. Yet it faces the challenge of intermediate (H2O2) escape from nanomaterials during systemic circulation if the enzyme pair is not strictly placed into close spatiotemporal proximity allowing complete H2O2 conversion, which imposes deleterious oxidative stress on normal tissues. Moreover, of the materials reported to deliver GOx and CAT/CAT‐like nanoenzymes, they are principally non‐biodegradable and not tumor microenvironment (TME)‐responsive. Therefore, in the present study, a multifunctional oxygen‐generating nanocascade, termed n(GOx‐CAT)C7A, which is constructed by strategically placing an enzymatic cascade (GOx and CAT) within a polymeric coating rich in pH‐responsive (hexamethyleneimine) (C7A) moieties, is reported. During blood circulation, C7A remains predominantly non‐protonated; therefore, n(GOx‐CAT)C7A can achieve long blood circulation and effective tumor accumulation through passive targeting due to its neutral and zwitterionic low‐fouling surface. As soon as n(GOx‐CAT)C7A reaches the tumor site, the acidic tumor microenvironment will induce abrupt protonation of C7A moieties, resulting in a positively charged surface for enhanced tumor transcytosis and retention. Moreover, GOx and CAT are covalently conjugated into close spatial proximity (< 10 nm) for effective H2O2 elimination and prevention of intermediate (H2O2) escape. As demonstrated by the subsequent in vitro and in vivo studies, n(GOx‐CAT)C7A achieved effective tumor retention and oxygenation, potent radiosensitization and antitumor effects, and low systemic toxicity. In addition, n(GOx‐CAT)C7A is biodegradable in response to the intracellular glutathione because the chemical linkers between GOx and CAT, and among polymer chains are disulfate linkers. Such a multistage‐responsive dual‐enzyme nanocascade for smart O2 delivery holds great potential for enhancing the current hypoxia‐compromised cancer therapies. This article is protected by copyright. All rights reserved

Prodrug-Based Nanoreactors with Tumor-Specific In Situ Activation for Multisynergistic Cancer Therapy

Prodrug-Based Nanoreactors with Tumor-Specific <i>In Situ</i> Activation for Multisynergistic Cancer Therapy

A Procedurally Activatable Nanoplatform for Chemo/chemodynamic Synergistic Therapy

Reduction-Responsive Chemo-Capsule-Based Prodrug Nanogel for Synergistic Treatment of Tumor Chemotherapy

Tumor-Selective Cascade-Amplified Dual-Prodrugs Activation for Synergistic Oxidation-Chemotherapy

Pd@Pt-GOx/HA As a Novel Enzymatic Cascade Nanoreactor for High-Efficiency Starving-Enhanced Chemodynamic Cancer Therapy.

Tumor-Specific ONOO – Nanogenerator for Improved Drug Delivery and Enhanced Chemotherapy of Tumor

Tumor Microenvironment Responsive Polypeptide-Based Supramolecular Nanoprodrugs for Combination Therapy

Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy

Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy

A Dual Functional Nanoreactor for Synergistic Starvation and Photodynamic Therapy

Reactive Oxygen Species Activatable Heterodimeric Prodrug as Tumor-Selective Nanotheranostics

Bioresponsive Prodrug Nanogel-Based Polycondensate Strategy Deepens Tumor Penetration and Potentiates Oxidative Stress

Promoting Oxidative Stress in Cancer Starvation Therapy by Site-Specific Startup of Hyaluronic Acid-Enveloped Dual-Catalytic Nanoreactors.

Multistage‐Responsive Dual‐Enzyme Nanocascades for Synergistic Radiosensitization‐Starvation Cancer Therapy

Acid-responsive Endosomolytic Polymeric Nanoparticles with Amplification of Intracellular Oxidative Stress for Prodrug Delivery and Activation.

Synergistically enhanced multienzyme catalytic nanoconjugates for efficient cancer therapy

Smart Unimolecular Micelles-based Polyprodrug with Dual Redox Stimuli-Response for Tumor Microenvironment: Enhanced In Vivo Delivery Efficiency and Tumor Penetration.

Autocatalytic Oncotherapy Nanosystem with Glucose Depletion for the Cascade Amplification of Hypoxia-Activated Chemotherapy and H2O2-dependent Chemodynamic Therapy.

Oxidation-strengthened disulfide-bridged prodrug nanoplatforms with cascade facilitated drug release for synergetic photochemotherapy

Reactive Oxygen Species-Activated Self-Accelerated Drug Release Nanoparticles for Enhanced Cancer Combination Therapy